Taking people in SpainPhase 1
Testing ZL-1310 Doses in Adults with Small Cell Lung Cancer
Tests the drug ZL-1310 in adults with small cell lung cancer.
Key facts
- Who runs it
- Zai Lab (US) LLC
- Where
- Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Sevilla, and Valencia, SpainSee the 11 sites
- Trial code
- Registry title
- A Study of ZL-1310 in Patients with Small Cell Lung Cancer to Find a Suitable Dose and to Test How Different Doses of ZL-1310 are Tolerated by the Body and How the Body Absorbs, Distributes, Metabolizes and Excretes ZL-1310
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 80 people, planned
- Started
- 21 Nov 2024
- Expected to end
- 30 Apr 2028
- Type of study
- Interventional
- Record updated
- 12 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with small cell lung cancer. It studies how different doses of ZL-1310 are tolerated and how the body handles the drug.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Small cell lung cancer. No further stage is given in the record.
Where in Spain
- Hospital HM Nou DelfosBarcelona, SpainTaking people
- Vall d'Hebron Institute of OncologyBarcelona, SpainTaking people
- Hospital Universitario 12 de OctubreMadrid, SpainTaking people
- Hospital Universitario HM SanchinarroMadrid, SpainTaking people
- Hospital Universitario Ramón y CajalMadrid, SpainTaking people
- Hospital Universitario Regional de MálagaMálaga, SpainTaking people
- Hospital Universitario Quironsalud MadridPozuelo de Alarcón, SpainTaking people
- Hospital Universitario Virgen De La MacarenaSevilla, SpainTaking people
- University Hospital Virgen Del Rocio S.L.Sevilla, SpainTaking people
- Hospital Clinico Universitario de ValenciaValencia, SpainTaking people
- Hospital Universitario Y Politecnico La FeValencia, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Testing ZL-1310 Doses in Adults with Small Cell Lung CancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 12 October 2026